Brightflow
Series A in 2024
Brightflow operates as a medical device startup.
Archeon Medical
Series A in 2022
Archeon Medical specializes in the development of innovative solutions aimed at enhancing the monitoring, diagnosis, and treatment of critically ill patients during prehospital care. The company utilizes artificial intelligence to create disruptive technologies that focus on improving ventilation quality in emergency medical services. Archeon Medical's products are practical, easy to use, and intuitive, providing emergency caregivers with real-time feedback on the quality of ventilation administered to patients. Through its commitment to advancing prehospital care, Archeon Medical seeks to optimize patient outcomes in critical situations.
NaoX Technologies
Venture Round in 2022
NaoX Technologies is a company focused on the prevention of neurological disorders through innovative technology. It develops wireless headphones equipped with integrated sensors that passively monitor brain vibrations to record electroencephalogram data in real time. This data is then aggregated and presented on a software dashboard for healthcare providers, facilitating better diagnosis and treatment for patients. The company's mission is to democratize access to neurological disorder prevention, aiming to enhance patient outcomes and support recovery from mental illness.
i-Virtual
Seed Round in 2021
i-Virtual specializes in advanced sensing technologies, enhancing AI's ability to perceive human vital signs with precision. Its flagship product, Saphere, is a video-based vital sign measurement engine enabling industries like insurance and wellness to harness real-time insights through simple selfies.
Gleamer develops AI-powered radiology software that acts as an automated second reader within clinicians' standard imaging workflows. Its AI companions automatically detect bone abnormalities and lesions on X-ray exams, highlighting findings and providing preliminary data to support diagnoses, speeding interpretation and helping radiologists prioritize patients. The tools integrate into routine reading environments and are deployed across multiple countries and institutions to improve diagnostic accuracy and efficiency in trauma and general radiography.
Epigene Labs
Seed Round in 2020
Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.
Founded in Paris in 2015, Lifen is a leading provider of digital health solutions in France. With over 600 partner establishments, it facilitates secure sharing of medical data among hospitals, doctors, and patients. Lifen's platform sends around 2 million documents monthly to approximately 240,000 healthcare practitioners. Recognized for its expertise in interoperability, the company aims to simplify technical integration and deployment of digital solutions.